.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
McKesson
Daiichi Sankyo
Federal Trade Commission
Citi
Accenture
Colorcon
Novartis
Baxter

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040481

« Back to Dashboard
NDA 040481 describes DIGOXIN, which is a drug marketed by Hikma Intl Pharms, Hospira, Abraxis Pharm, West-ward Pharms Int, Impax Labs, Sun Pharm Inds Inc, Stevens J, Sandoz Inc, Mylan Pharms Inc, and Wyeth Ayerst, and is included in thirteen NDAs. It is available from thirty-two suppliers. Additional details are available on the DIGOXIN profile page.

The generic ingredient in DIGOXIN is digoxin. There are ten drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the digoxin profile page.

Summary for 040481

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 040481

Ingredient-typeCardiac Glycosides

Medical Subject Heading (MeSH) Categories for 040481

Suppliers and Packaging for NDA: 040481

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIGOXIN
digoxin
INJECTABLE;INJECTION 040481 ANDA Sandoz Inc 0781-3059 0781-3059-95 10 AMPULE in 1 CARTON (0781-3059-95) > 2 mL in 1 AMPULE (0781-3059-72)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.25MG/ML
Approval Date:Aug 21, 2003TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Cantor Fitzgerald
Julphar
Covington
Cerilliant
Novartis
Fuji
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot